These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Pharmacokinetics of mezlocillin in patients with kidney impairment: special reference to hemodialysis and dosage adjustments in relation to renal function. Brogard JM; Comte F; Spach MO; Lavillaureix J Chemotherapy; 1982; 28(5):318-26. PubMed ID: 6216076 [TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetics of intravenous mezlocillin in patients with normal and impaired renal function (author's transl)]. Cano JP; Rigault JP; Gevaudan MJ; Saingra S; Murisasco A; Charpin J Nouv Presse Med; 1982 Feb; 11(5 Pt 2):335-9. PubMed ID: 6460972 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of mezlocillin during haemodialysis. Thorsteinsson SB; Steingrimsson O; Asmundsson P; Bergan T Scand J Infect Dis Suppl; 1981; 29():59-63. PubMed ID: 6458883 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of mezlocillin and sulbactam under continuous veno-venous hemodialysis (CVVHD) in intensive care patients with acute renal failure. Rohde B; Werner U; Hickstein H; Ehmcke H; Drewelow B Eur J Clin Pharmacol; 1997; 53(2):111-5. PubMed ID: 9403281 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of piperacillin in patients with moderate renal failure and in patients undergoing hemodialysis. Giron JA; Meyers BR; Hirschman SZ; Srulevitch E Antimicrob Agents Chemother; 1981 Feb; 19(2):279-83. PubMed ID: 6214987 [TBL] [Abstract][Full Text] [Related]
11. Elimination kinetics of mezlocillin in normal and impaired renal function including the effects of dialysis. Kosmidis J; Doundoulaki P; Stathakis C; Zerefos N; Bounia A; Daikos GK Arzneimittelforschung; 1979; 29(12a):1960-2. PubMed ID: 543901 [TBL] [Abstract][Full Text] [Related]
12. [Pharmacokinetics and dosage of mezlocillin administered by intravenous infusion]. Modr Z; Dvorácek K; Janků I; Krebs V Infection; 1982; 10 Suppl 3():S191-5. PubMed ID: 6218111 [TBL] [Abstract][Full Text] [Related]
13. [Pharmacokinetics of intramuscular mezlocillin in patients with normal and impaired renal function (author's transl)]. Brogard JM; Comte F; Kopferschmitt J; Dorner M; Lavillaureix Nouv Presse Med; 1982 Feb; 11(5 Pt 2):340-6. PubMed ID: 6460973 [TBL] [Abstract][Full Text] [Related]
14. Nonlinear mezlocillin kinetics due to dose-dependent metabolism. Gundert-Remy U; Hildebrandt R; Stiehl A; Weber E Clin Pharmacol Ther; 1983 May; 33(5):656-62. PubMed ID: 6220858 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of intravenous piperacillin in patients undergoing chronic hemodialysis. Francke EL; Appel GB; Neu HC Antimicrob Agents Chemother; 1979 Dec; 16(6):788-91. PubMed ID: 533260 [TBL] [Abstract][Full Text] [Related]
16. Dose-dependent pharmacokinetics of azlocillin compared to mezlocillin. Bergan T; Thorsteinsson SB; Steingrimsson O Chemotherapy; 1982; 28(3):160-70. PubMed ID: 6212204 [TBL] [Abstract][Full Text] [Related]
17. [Pharmacokinetics of mezlocillin. Comparison with ampicillin and influence of probenecid (author's transl)]. Verbist L; Tjandramaga TB; Verbesselt R; de Schepper PJ Nouv Presse Med; 1982 Feb; 11(5 Pt 2):347-52. PubMed ID: 6460974 [TBL] [Abstract][Full Text] [Related]